These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3937292)

  • 1. HLA antigens in schistosomal hepatic fibrosis patients with haematemesis.
    Abaza H; Asser L; el Sawy M; Wasfy S; Montaser L; Hagras M; Shaltout A
    Tissue Antigens; 1985 Nov; 26(5):307-9. PubMed ID: 3937292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA class I antigens (A1, B5, B8 and CW2) with disease manifestations and infection in human schistosomiasis mansoni in Egypt.
    Abdel-Salam E; Abdel Khalik A; Abdel-Meguid A; Barakat W; Mahmoud AA
    Tissue Antigens; 1986 Mar; 27(3):142-6. PubMed ID: 3087019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the association between HLA-A1 and B5 and clinical forms of schistosomiasis mansoni.
    Cabello PH; Krieger H; Lopes JD; Sant'Ana EJ
    Mem Inst Oswaldo Cruz; 1991; 86(1):37-40. PubMed ID: 1842399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA typing intestinohepatic schistosomiasis.
    el-Hawy AM; el-Tayeb S; Salem SN; el-Nasr MS; Sabry H
    J Egypt Soc Parasitol; 1989 Dec; 19(2):417-25. PubMed ID: 2504821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic susceptibility for post-schistosomal hepatic fibrosis.
    Hafez M; Aboul Hassan S; el-Tahan H; el-Shennawy F; Khashaba M; al-Tonbary Y; el-Morsi Z; el-Sallab S; el-Desoky I; el-Shazly A
    Am J Trop Med Hyg; 1991 Apr; 44(4):424-33. PubMed ID: 1904196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered lymphocyte proliferation and cytokine release in hepatosplenic schistosomiasis mansoni in Brazil.
    Zwingenberger K; Jansen-Rosseck R; Cardoso AE; de Siqueira JG; Feldmeier H
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():273-6. PubMed ID: 3151103
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-A,B,C and DR antigens in Egyptian patients with schistosomal hepatosplenomegaly.
    Zakaria S; Kamel MA; Mabrouk MA; Zakaria E
    J Egypt Soc Parasitol; 1988 Jun; 18(1):253-7. PubMed ID: 3131445
    [No Abstract]   [Full Text] [Related]  

  • 8. Histocompatibilty-linked susceptibility for hepatospleenomegaly in human schistosomiasis mansoni.
    Salam EA; Ishaac S; Mahmoud AA
    J Immunol; 1979 Oct; 123(4):1829-31. PubMed ID: 479601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A,B,C and DR antigens in Egyptian patients with schistosomal colonic polyposis.
    Kamel MA; Zakaria S; Mabrouk MA; Zakaria E
    J Egypt Soc Parasitol; 1987 Dec; 17(2):609-13. PubMed ID: 3121765
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of reduced antibody response to "SMW68" (an affinity purified schistosomal antigen) with hepatosplenomegaly in Egyptian schoolchildren infected with Schistosoma mansoni.
    el-Hawey AM; Mahmoud AA; King CH; Amer ME
    J Egypt Soc Parasitol; 1990 Dec; 20(2):513-9. PubMed ID: 2121845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation and schistosomiasis mansoni.
    Azevedo LS; de Paula FJ; Ianhez LE; Saldanha LB; Sabbaga E
    Transplantation; 1987 Dec; 44(6):795-8. PubMed ID: 2962342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease.
    Elsammak MY; Al-Sharkaweey RM; Ragab MS; Amin GA; Kandil MH
    Parasite Immunol; 2008; 30(11-12):603-9. PubMed ID: 19067841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some genetic, clinical and immunologic interrelations in schistosomiasis mansoni.
    Assaad-Khalil SH; Helmy MA; Zaki A; Mikhail MM; el-Hai MA; el-Sawy M
    Ann Biol Clin (Paris); 1993; 51(6):619-26. PubMed ID: 8172401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated intravascular coagulation in endemic hepatosplenic schistosomiasis.
    Omran SA; el-Bassiouni NE; Hussein NA; Akl MM; Hussein AT; Mohamed AA
    Haemostasis; 1995; 25(5):218-28. PubMed ID: 7489960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of porto-systemic shunts in the specific humoral immune response in patients with schistosomal hepatic fibrosis.
    Helmy-Khalil S; Khalil SA; el Sawy M; Youssef M; el Kader MA; el Hallous D; el Balassy F; Souka M; el Girby A; Fahmy MH
    Ann Biol Clin (Paris); 1985; 43(6):856-60. PubMed ID: 3938625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some immunological aspects on human Schistosoma mansoni infection in Egypt.
    el Marsafy A; el Okbi SM; el Adawy N
    J Egypt Soc Parasitol; 1993 Apr; 23(1):179-87. PubMed ID: 8482864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hepatic fibrosis: clinical presentation, laboratory features and management at a tertiary care hospital of Lahore.
    Parkash A; Cheema HA; Malik HS; Fayyaz Z
    J Pak Med Assoc; 2016 Aug; 66(8):984-8. PubMed ID: 27524533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte subpopulation in early and late schistosomal hepatosplenomegaly.
    Hassan T; Mostafa A; Khalil R; Hassan O; Abd el Ghany S; Massoud S
    Chemioterapia; 1987 Jun; 6(2 Suppl):213-4. PubMed ID: 2978387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recurrent hematemesis in a patient from Yemen with splenomegaly].
    Ritter MM; Jüngst D; Paumgartner G
    Internist (Berl); 1987 Dec; 28(12):825-7. PubMed ID: 3125121
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatosplenic schistosomiasis.
    Lubeya M; Muloshi C; Baboo KS; Sianongo S; Kelly P
    Lancet; 2010 Nov; 376(9753):1645. PubMed ID: 21075257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.